CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 70 enrolled
Drug / intervention
Systane Complete Multi-Dose PF +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06219577
NCT06219577Phase 4Completed

Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant Balance

Scripps Poway Eyecare and Optometry·interventional·Posted Jan 23, 2024·Updated Apr 8, 2025

In Brief

A Phase 4 clinical trial evaluating Systane Complete Multi-Dose PF and Walgreen's Lubricant Balance for Dry Eye. Completed, enrolled 70 participants across 1 site.

Detailed Summary

Single site, prospective, double-masked, randomized-controlled, two-arm study of the dry eye symptoms as well as corneal and conjunctival staining in subjects using 2 different eyedrops. Subjects will be assessed at a screening visit, and 2 follow-up visits. Clinical evaluations will include patient questionnaire, tear-breakup time, and slit lamp exam.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye
CountriesUnited States
CollaboratorsSengi

Timeline

Phase 4CompletedFinished
202420252026
First PostedJan 23, 2024
Enrollment StartJan 18, 2024
Primary CompletionApr 22, 2024
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 2.4 years ago

Interventions

Systane Complete Multi-Dose PFdrug

Eyedrop

Walgreen's Lubricant Balancedrug

Eyedrop